The Cost Effectiveness Of Enhanced External Counterpulsation (EECP®) Therapy

Posted by 18 December, 2009 (0) Comment

Approximately 6.8 meg grouping in the United States undergo from angina, with 400,000 newborn cases diagnosed annually, and 80,000-100,000 patients are disobedient and undergo from cardiopathy or cardiopathy equal symptoms.

The Centers for Medicare and Medicaid Services (CMS) and some another third-party shelter payers wage news for patients who hit been diagnosed with unhealthful cardiopathy (Class threesome or Class IV, river Cardiovascular Society or equal classification) who, in the instrument of a specialist or cardiothoracic surgeon, are not pronto compliant to preoperative intervention, much as PCI or cardiac road because:

1. Their information is inoperable, or at broad venture of functioning complications or post-operative failure,
2. Their thrombosis morphology is not pronto compliant to much procedures; or
3. They hit co-morbid states, which create unrestrained risk.

 

There are 5 meg patients in the United States and roughly 22 meg worldwide pain from hunch failure. It is the directive drive of hospitalizations in patients over the geezerhood of 65, and is digit of the maximal burdens on the U.S. aid system, costing in immoderateness of $20 1000000000 annually.

EECP® therapy offers an possibleness to redefine the accepted of tending in how this assemble of patients is aerated and has been demonstrated to turn both crisis shack (ER) visits and hospitalizations in hunch unfortunate patients with mitt ventricular pathology by 86% and 83% respectively, from 1.4 to 0.2 ER visits and 2.4 to 0.4 hospitalizations per enduring per year.

The EECP® therapy system, a non-invasive outpatient therapy for the communication of diseases of the cardiovascular system, serves to process circulation in areas of the hunch with inferior than competent murder cater and helps to change systemic tube function; increases murder line and gas cater to the hunch hooligan and another organs, and decreases the heart’s workload and reduces gas demand; and improves duty of the endothelium, the covering of murder vessels throughout the body, modification status to murder flow. EECP® Therapy treats steady or changeful angina, congestive hunch failure, accent myocardial infarction, and cardiogenic shock.

Popularity: 2% [?]

Categories : Economics Tags : , , , , , , , , , , , , , , ,